Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response Monitoring in Cervical Cancer After Radio-chemotherapy
NCT03559803Unknown
- Sponsor
- Sichuan University
- Start
- Oct 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cisplatin in Cervical Cancer (CC), sponsored by Sichuan University. Primary endpoint: The change of expression of PD-L1+ on cervix biopsies at 2 months. Status: unknown.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT03559803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03559803.